Aeterna Zentaris
AEZS
#10194
Rank
A$24.68 M
Marketcap
A$8.06
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

Earnings for Aeterna Zentaris (AEZS)

Earnings in 2024 (TTM): -A$8.26 Million

According to Aeterna Zentaris's latest financial reports the company's current earnings are A$6.32 Million. In 2023 the company made an earning of -A$4.72 Million a decrease over its 2022 earnings that were of A$5.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aeterna Zentaris from 1997 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$8.26 Million75.06%
2023 -A$4.72 Million-193.05%
2022 A$5.06 M118.42%
2021 A$2.32 M66.11%
2020 A$1.39 M-251.06%
2019 -A$0.93 Million25.51%
2018 -A$0.74 Million72.53%
2017 -A$0.43 Million-109.78%
2016 A$4.36 M49.97%
2015 A$2.91 M61.77%
2014 A$1.8 M597.94%
2013 A$0.25 M-134.11%
2012 -A$0.76 Million-182.25%
2011 A$0.91 M-50.2%
2010 A$1.84 M1084.23%
2009 A$0.15 M-109.18%
2008 -A$1.7 Million-6.23%
2007 -A$1.82 Million752.47%
2006 -A$0.22 Million269.03%
2005 -A$0.06 Million-84.64%
2004 -A$0.38 Million9.96%
2003 -A$0.35 Million184.21%
2002 -A$0.12 Million-69.93%
2001 -A$0.4 Million-22.76%
2000 -A$0.52 Million-13.94%
1999 -A$0.61 Million-31.33%
1998 -A$0.88 Million-84.12%
1997 -A$5.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$23.04 B-298,195.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$12.82 B-165,996.94%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$11.32 B-146,540.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$87.23 Million 1,028.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$1.05 B-13,698.38%๐Ÿ‡บ๐Ÿ‡ธ USA